
Platikem 50mg Infusion
Marketer
Alkem Laboratories Ltd
Salt Composition
Cisplatin (50mg)
Overview Platikem 50mg Infusion
Cisplatin 50mg intravenous infusion is a prescription medication employed in the management of ovarian, cervical, and testicular cancers. Its mechanism involves inhibiting or retarding cancerous cell proliferation. Administration is via intravenous injection by a qualified healthcare professional, with dosage and frequency determined by your physician based on your specific condition and potentially adjusted over time. Adhere strictly to your doctor's prescribed regimen; incorrect usage or overdosage can lead to severe adverse reactions. Therapeutic benefits may not be apparent for several weeks or months; discontinue only upon your doctor's instruction. Common side effects include injection site inflammation (pain, swelling, erythema), nausea, and emesis. Ototoxicity (hearing impairment or damage) is a serious potential side effect, necessitating pre- and ongoing audiological assessments. Myelosuppression (reduction in blood cell counts) increasing infection risk is possible; regular blood tests monitoring blood cell levels, along with cardiac, hepatic, and renal function are mandatory. Prior to commencing treatment, disclose any history of or existing renal impairment, as this medication impacts kidney function. Inform your healthcare provider of all other medications you are taking, as interactions are possible. This medication is contraindicated during pregnancy and lactation. Male infertility is a potential consequence; consultation regarding sperm cryopreservation before treatment initiation is advised.
Uses of Platikem 50mg Infusion
Cancers affecting the ovaries, cervix, and testes.
Major Benefits of Platikem 50mg Infusion:
This medication will be administered by your healthcare provider. Self-medication is not advised.
Common Side effects of Platikem 50mg Infusion:
- Injection site reactions (pain, swelling, redness)
- Increased risk of infection
- Ear disorder
- Vomiting
- Nausea
- Decreased blood cells (red cells, white cells, and platelets)
- Renal impairment
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Kidney damage
- Hearing loss
- Ringing in ear
How to use Platikem 50mg Infusion:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Platikem 50mg Infusion works:
Infusing Platikem 50mg exerts an anti-neoplastic effect by disrupting the cancerous cells' DNA and RNA, thereby inhibiting their proliferation.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Platikem 50mg Infusion lacks established safety data. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Platikem 50mg Infusion during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is mandatory.
Breast feedingUNSAFE
Administering Platikem 50mg Infusion while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Administering Platikem 50mg Infusion may induce adverse reactions, including drowsiness and nausea, potentially impairing driving ability.
KidneyCAUTION
Caution is advised when administering 50mg Platikem Infusion to individuals with impaired renal function; dosage modification may be necessary. Physician consultation is recommended. Platikem 50mg Infusion is contraindicated in patients exhibiting severe kidney disease.
LiverSAFE IF PRESCRIBED
The use of 50mg Platikem Infusion in patients with hepatic impairment is likely safe. Current evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
What if you forget to take Platikem 50mg Infusion :
Omitting a scheduled dose of Platikem 50mg Infusion requires immediate physician consultation.
Facts to Know About Platikem 50mg Infusion
| Label | Value |
|---|---|
| Type of Compound | Platinum-based compounds |
| Potential for Dependence | None. |
| Medication Category | Cancer treatments |
| Mechanism of Action | Platinum-based anti-cancer agents |
